Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-06

Clinical Trial Update: The Use of Bellafill for Atrophic Acne Scar Correction in the Full Facial Area [NA]

View source ↗

Summary

Clinical trial update on using Bellafill for correcting atrophic acne scars across the full facial area; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bellafill (polymethyl methacrylate (PMMA))

Snippet

Sponsor: Suneva Medical, Inc. | Conditions: Atrophic Acne Scarring | NA | Status: COMPLETED | Results posted: 2020-04-06